Avricore Health (AVCRF) Operating Leases (2009 - 2019)

Avricore Health (AVCRF) posted quarterly Operating Leases of $16202.9 for Q4 2019, down 98.27% sequentially from $934921.6 in Q1 2009.

Avricore Health (AVCRF) Operating Leases (2009 - 2019) Analysis & Trends

Avricore Health has disclosed Operating Leases across 2 years of filings, most recently posting $16202.9 for Q4 2019.

In Q4 2019, Operating Leases changed N/A year-over-year to $16202.9; the TTM figure through Dec 2019 stood at $16202.9 (changed N/A YoY), while the FY2019 annual figure was $16121.2, changed N/A from the prior year.
Operating Leases retreated to $16202.9 in Q4 2019, from $934921.6 in the prior quarter.
Over the last five years, Operating Leases for AVCRF reached as high as $16202.9 in Q4 2019 and fell as low as $16202.9 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Avricore Health	-	-	-

Download Data

Date	Value
Dec 31, 2019	16,202.89
Mar 31, 2009	934,921.61